AA
MRNA icon

Alta Advisers’s Moderna MRNA Stock Holding History

Alta Advisers’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,000
Closed -$66.8K – 316
2024
Q3 		$66.8K Hold
1,000
– – 0.03% 378
2024
Q2 		$119K Hold
1,000
– – 0.06% 215
2024
Q1 		$107K Hold
1,000
– – 0.05% 260
2023
Q4 		$99.5K Hold
1,000
– – 0.05% 259
2023
Q3 		$103K Hold
1,000
– – 0.06% 226
2023
Q2 		$122K Hold
1,000
– – 0.07% 191
2023
Q1 		$154K Hold
1,000
– – 0.09% 135
2022
Q4 		$180K Hold
1,000
– – 0.11% 111
2022
Q3 		$118K Buy
+1,000
New +$152K 0.07% 161

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Alta Advisers's MRNA Position: Q4 2024 in Review

Alta Advisers sold out of Moderna (MRNA) in Q4 2024, closing a stake of 1,000 shares — an estimated $66.8K sold.

Alta Advisers first reported a position in MRNA in Q3 2022 and held it in 9 quarters. The position peaked at $180K in Q4 2022. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Alta Advisers reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Alta Advisers sold 1,000 Moderna shares in Q4 2024, an estimated $66.8K.
  • Alta Advisers first reported a position in Moderna in Q3 2022 and held it in 9 quarters.
  • Alta Advisers's Moderna position peaked at $180K in Q4 2022.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Alta Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.